Loading
Urinary Tract Infections Management / Neutropenia and Cancer Infections · Journal article
Frontiers in Pharmacology · August 20, 2026
A consensus or society position rather than new primary data.
This is a policy brief synthesizing institutional experience and expert opinion to recommend strategies for managing bacterial infections and antimicrobial resistance in cancer patients across sub-Saharan Africa. It does not present primary research data or comparative evidence but calls for multidisciplinary collaboration and health policy action in cancer centres.
Journal article. Cancer patients with bacterial infections in sub-Saharan Africa. Sub-Saharan Africa (informed by Uganda Cancer Institute data since 2014).
Cancer patients are 1.5–2 times more likely to be affected by antimicrobial resistance than other patient groups.
No quantitative data on infection prevalence, mortality, or intervention effectiveness in SSA cancer populations.
This brief informs policy-makers and cancer centre leadership in SSA that antimicrobial resistance expertise must be integrated into cancer care delivery, and provides a framework for strengthening surveillance, stewardship, and infection prevention. It is intended to guide institutional and sectoral decision-making rather than individual clinical practice.
A policy brief presenting expert recommendations for managing infections in cancer patients amid antimicrobial resistance in sub-Saharan Africa, informed by institutional microbiological data but not a primary research study.
As stated by the source record.
Quoted from the source exactly as published.
This brief informs policy-makers and cancer centre leadership in SSA that antimicrobial resistance expertise must be integrated into cancer care delivery, and provides a framework for strengthening surveillance, stewardship, and infection prevention. It is intended to guide institutional and sectoral decision-making rather than individual clinical practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Antimicrobial resistance (AMR) is a global health concern. Cancer patients are 1.5-2 times more likely to be affected by AMR than other patient groups. This policy brief, informed by microbiological studies conducted at the Uganda Cancer Institute since 2014, presents key recommendations and implementation strategies for the management of bacterial infections in cancer patients in sub-Saharan Africa (SSA). Our recommendations include strengthening AMR surveillance, implementing context-specific infection prevention and control and antimicrobial stewardship programs, and raising awareness of AMR in cancer in the health sector and community in SSA. A collaborative multidisciplinary approach which includes infectious diseases expertise is required to effectively implement health policies and guidelines. Proactive and effective health policies which address AMR in cancer are critical in cancer centers in SSA.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.